Literature DB >> 1671679

Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1.

P N Fultz1, R L Siegel, A Brodie, A C Mawle, R B Stricker, R B Swenson, D C Anderson, H M McClure.   

Abstract

The immunologic and virologic status of a chimpanzee inoculated with multiple isolates of the human immunodeficiency virus type 1 (HIV-1) were assessed over 57 months to determine whether prolonged thrombocytopenia and CD4+ lymphocytopenia observed in the animal might be associated with long-term HIV infection. Although the chimpanzee showed no signs of disease, it lost both CD4+ (as low as 134 cells/microliter) and CD8+ lymphocytes approximately 30 months after initial infection, followed by thrombocytopenia that has persisted for greater than 2 years. Lymphopenia and thrombocytopenia were preceded by or coincided with the appearance of antibodies cross-reactive with histone H2B and decreased levels of complement component C4; an eightfold decrease in HIV-specific antibody titers; the inability of CD8+ lymphocytes to suppress virus replication; impaired proliferative responses to T cell mitogens; and the isolation of cell-free HIV from plasma. These data suggest that, given sufficient time, HIV-infected chimpanzees may develop disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671679     DOI: 10.1093/infdis/163.3.441

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

2.  Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.

Authors:  I C Davis; M Girard; P N Fultz
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease.

Authors:  M Watanabe; D J Ringler; P N Fultz; J J MacKey; J E Boyson; C G Levine; N L Letvin
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Nonhuman Primate Models and Understanding the Pathogenesis of HIV Infection and AIDS.

Authors:  Ronald S Veazey; Andrew A Lackner
Journal:  ILAR J       Date:  2017-12-01

5.  Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1.

Authors:  F J Novembre; M Saucier; D C Anderson; S A Klumpp; S P O'Neil; C R Brown; C E Hart; P C Guenthner; R B Swenson; H M McClure
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS.

Authors:  Q Wei; P N Fultz
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.

Authors:  K Saksela; E Muchmore; M Girard; P Fultz; D Baltimore
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 8.  Humanized mice for the study of infectious diseases.

Authors:  Michael A Brehm; Nathalie Jouvet; Dale L Greiner; Leonard D Shultz
Journal:  Curr Opin Immunol       Date:  2013-06-08       Impact factor: 7.486

9.  Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors.

Authors:  Akatsuki Saito; Hirofumi Akari
Journal:  Front Microbiol       Date:  2013-07-09       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.